Janux Therapeutics Inc

NASDAQ:JANX   3:59:51 PM EDT
30.97
+1.18 (+3.96%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)1.29B
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$0.13 Million
Adjusted EPS-$0.18
See more estimates
10-Day MA$29.98
50-Day MA$29.94
200-Day MAN/A
See more pivots

Janux Therapeutics Inc Stock, NASDAQ:JANX

11099 North Torrey Pines Park, Suite 290, La Jolla, California 92037
United States of America
Phone: +1.858.750.4700
Number of Employees:

Description

Janux Therapeutics, Inc. operates preclinical stage biopharmaceutical company which engages in developing therapeutics based on the Tumor Activated T Cell Engager platform technology. The company was founded in June 2017 and is headquartered in La Jolla, CA.